Search Results

Site Search

Phlebotomy modules - Insights

Our interactive learning modules encompass many of the necessary skills to further develop your knowledge and skills on your journey as a phlebotomist.

Histiocytic neoplasms - Insights

Learn more about how Mayo Clinic Laboratories’ next-generation sequencing panel for histiocytic neoplasms can help physicians accurately diagnose patients and guide treatment for their patients.

Jason Hipp, M.D., Ph.D., named chair of DLMP's new Division of Clinical Informatics - Insights

Dr. Hipp is a board-certified pathologist with fellowship training in pathology informatics, as well as artificial intelligence, machine, and deep-learning experience.

Psychotropic PGx Panel for Drug Treatment Optimization [Test in Focus] - Insights

Ann Moyer, M.D., Ph.D. gives an overview of this new test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can...

Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 20 - Insights

This week’s Research Roundup highlights prehospital transfusion for gastrointestinal bleeding.

Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 7 - Insights

This week’s Research Roundup highlights a randomized controlled trial of postoperative belladonna and opium rectal suppositories in vaginal surgery.

Mayo Clinic Laboratory and Pathology Research Roundup: May 28 - Insights

This week’s Research Roundup highlights the clinical and pathology findings associated consistently with larger glomerular volume.

Mayo Clinic Laboratory and Pathology Research Roundup: June 12 - Insights

This week’s Research Roundup highlights noninvasive assessment of renal fibrosis with magnetization transfer MR imaging.

What You Should Know about Rocky Mountain Spotted Fever - Insights

A Wisconsin woman has died of Rocky Mountain spotted fever in what Wisconsin health officials have confirmed is the first documented death from the infection in the state. Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory...

Mayo Clinic Laboratory and Pathology Research Roundup: March 11 - Insights

This week’s Research Roundup highlights an assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients and several other research articles by Mayo Clinic physicians...

Mayo Clinic Laboratory and Pathology Research Roundup: March 13 - Insights

This week’s Research Roundup highlights the clinical and pathological evolution of giant cell arteritis with a prospective study of follow-up temporal artery biopsies in 40 treated patients.

Tissue testing for COVID-19 - Insights

Being able to identify SARS-CoV-2 in tissue is key to better understand the virus that causes COVID-19. Now, a first-of-its-kind test that detects SARS-CoV-2 in formalin-fixed, paraffin-embedded tissue is available from Mayo Clinic...

Collaborations - Insights

Mayo Clinic Laboratories’ BioPharma Diagnostics team facilitates customized collaborations with diagnostic companies to support their clinical and research testing needs.

Diagnostic and companion testing - Insights

Learn more about how diagnostic and companion testing can confirm a prenatal genetic diagnosis.

Hereditary epilepsy - Insights

Find out how we perform in-depth mutation and copy number variant analysis to determine causes of epilepsy and identify potential treatment options.

Chromosomal microarray - Insights

Learn how our microarray evaluations identify, analyze, and assess clinically significant chromosomal abnormalities.

Newborn Screening at Mayo Clinic Laboratories

Newborn screening is intended to detect serious health conditions in babies for which early intervention can greatly improve healthy development and positive outcomes.

Melanoma - Insights

Learn how our melanoma testing identifies variants in 17 genes associated with diagnosis, prognosis, and treatment guidance.

Rapid hereditary breast cancer - Insights

Learn how our rapid breast cancer treatment panel delivers results in 10 to 14 days and detects 11 genes linked to lifetime breast cancer risk.

COVID-19 weekly news: March 7-11 2022 - Insights

Topic's Include: Losing sleep during the pandemic? It may be affecting your weight, heart, and overall health, and how to deal with anxiety, stress when the world feels overwhelming.

Week in Review: April 29 - Insights

Today's highlights include: CDC estimates 3 in 4 kids have had coronavirus infections, virtual in-person cardiac rehabilitation provide similar benefits, and Mayo Clinic partners with AI startup to co-develop precision medicine.

Week in Review: May 6 - Insights

Today's highlights include: Mental health needs rise as pandemic fluctuates, an algorithm that analyzes apple watch data shows early promise in detecting heart problems, and Minnesota physicians brace for Roe v. Wade decision

Nonalcoholic Steatohepatitis (NASH)-FibroTest* [Test in Focus] - Insights

Nikola Baumann, Ph.D., gives an overview of the new NASH-FibroTest available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical...

Hereditary peripheral neuropathy - Insights

Learn how our test menu can assist in identifying genetic causes across the spectrum of hereditary peripheral neuropathies.

Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 11 - Insights

This week’s Research Roundup highlights autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease.

Michael Camilleri, M.D., and Leslie Donato, Ph.D., Discuss Testing for Bile Acid Malabsorption in Clinical Practice - Insights

In a recent issue of Mayo Clinic's Digestive Diseases, Michael Camilleri, M.D., a gastroenterologist at Mayo Clinic, and Leslie Donato, Ph.D., Co-Director for Cardiovascular Laboratory Medicine, Hospital Clinical Laboratory, and Point of...

Mayo Clinic Laboratory and Pathology Research Roundup: May 7 - Insights

This week’s Research Roundup highlights how fasting blood-glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis.

When the Body Attacks the Brain: Immune System Often to Blame for Encephalitis, Study Finds - Insights

Encephalitis caused by the immune system attacking the brain is similar in frequency to encephalitis from infections, Mayo Clinic researchers report in Annals of Neurology.

Research Suggests Genetics Are Key in Treating Night Sweats - Insights

Hormone therapy is often used to prevent night sweats. But finding the right dose of estrogen can be tricky, with some women needing more estrogen than others to get relief. A new Mayo Clinic study published in Menopause: The Journal of the...

Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 13 - Insights

This week’s Research Roundup highlights how the DnaJ heat shock protein family B member 9 is a novel biomarker for fibrillary GN.

Mayo Clinic Laboratory and Pathology Research Roundup: Dec. 10 - Insights

This week’s Research Roundup highlights the evaluation of monoclonal gammopathy of renal significance: A consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Ann Moyer, M.D., Ph.D., Makes a Case for Pharmacogenomics - Insights

Pharmacogenomic testing is still limited, despite ample research, the existence of guidelines, and the emerging evidence it can help patients. Ann Moyer, M.D., Ph.D., Co-Director of the Personalized Genomics Laboratory at Mayo Clinic in...

Mayo Clinic Discovers Biological Markers That Could Guide Treatment for Prostate Cancer - Insights

Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbor higher-risk cancer in their prostate glands, Mayo Clinic has discovered.

Ticks and the Art of Finding Beauty in Dreadful, Wonderful Parasites - Insights

Bobbi Pritt, M.D., spends her work hours identifying and diagnosing infectious diseases. In her free time, she celebrates their beauty by creating bug-related artwork and blogging about parasites.

Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 16 - Insights

This week’s Research Roundup highlights the role of deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy.

Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 26 - Insights

This week’s Research Roundup highlights the effect of inorganic nitrite versus a placebo on exercise capacity among patients with heart failure with preserved ejection fraction.

Mayo Clinic Laboratory and Pathology Research Roundup: Jan. 14 - Insights

This week’s Research Roundup highlights the identification of prognostic phenotypes of esophageal adenocarcinoma in two independent cohorts.

Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 20 - Insights

This week’s Research Roundup highlights how fasting blood glucose levels provide an estimate of duration and progression of pancreatic cancer before diagnosis.

MCL - Complement Component Deficiency and Hereditary Angioedema Patient Information - MC1235-313

MCL - Complement Component Deficiency and Hereditary Angioedema Patient Information

Mayo Clinic Laboratory and Pathology Research Roundup: April 17 - Insights

This week’s Research Roundup highlights autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease.

Large Scale Study: Outcomes for Long QT Syndrome Patients Treated at Specialty Center Are Better - Insights

Sudden cardiac death and episodes of fainting and seizures from long QT syndrome are significantly lower than previously thought when patients are diagnosed and treated at a specialty center dedicated to the treatment of genetic heart...

Porphyrias - Insights

Learn more about how Mayo Clinic Laboratories’ testing can assist in diagnosis and differentiation of porphyrias and help guide treatment decisions

Cholesterol biosynthesis and transport - Insights

Check out Mayo Clinic Laboratories’ testing approach to diagnose disorders related to cholesterol biosynthesis and transport.

Exploratory testing - Insights

Mayo Clinic Laboratories’ whole exome and whole genome sequencing assays provide in-depth interrogation of all the genes in the human genome, offering individualized insights for optimal outcomes.

Biopharma solutions - Insights

Inspired by Mayo Clinic’s tradition of collaboration to break down barriers, expand knowledge, and change medicine, BioPharma Diagnostics brings unmatched expertise and quality to each project. Whether supporting clinical trials, advancing...

Rare diseases - Insights

Effective testing is vitally important for diagnosis, prognosis, and disease management. With more than 90% of the 7,000 identified rare diseases lacking FDA-approved treatment,1 and patients waiting between 8 and 10 years before diagnosis,...

Hereditary neuromuscular disorders - Insights

Find out how our distinctive approach to evaluating for inherited neuromuscular disorders uses phenotypic information to streamline diagnosis.

Specialty testing - Insights

Commercial laboratories partners have access to Mayo Clinic Laboratories full menu of subspecialty testing, which spans the spectrum of medical specialties.

Colorectal and GI Cancer Testing - Mayo Clinic Laboratories

The results and interpretations from our laboratories provide clinically actionable results to guide treatment selection, ensuring every patient receives the medication most appropriate for care.

Primary ciliary dyskinesia - Insights

Learn more about Mayo Clinic Laboratories’ robust approach to testing for primary ciliary dyskinesia, a rare genetic condition that can lead to chronic otosinopulmonary disease and infertility in men.